ORIC Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-45.3M | $-45.9M | $667.0K | $5.3M |
| FY2021 | $-59.5M | $-60.5M | $939.0K | $12.9M |
| FY2022 | $-75.1M | $-77.2M | $2.1M | $14.5M |
| FY2023 | $-85.7M | $-86.5M | $849.0K | $15.2M |
| FY2024 | $-112.7M | $-113.9M | $1.2M | $20.2M |